| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
10,246 |
9,337 |
$704K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,831 |
3,767 |
$148K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,837 |
1,837 |
$129K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
644 |
644 |
$40K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,027 |
1,019 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
392 |
374 |
$912.43 |
| 81003 |
|
1,388 |
1,331 |
$76.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
31 |
$11.58 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
74 |
72 |
$6.92 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
77 |
72 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
30 |
30 |
$0.00 |
| A9150 |
Non-prescription drugs |
166 |
159 |
$0.00 |
| 87070 |
|
84 |
78 |
$0.00 |
| 94760 |
|
440 |
425 |
$0.00 |
| 93000 |
|
14 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
16 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
68 |
67 |
$0.00 |
| 81025 |
|
144 |
137 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
36 |
36 |
$0.00 |